INTERHOSPITAL CONFERENCE 21 DEC 2007 Physical examination Thai

  • Slides: 44
Download presentation
INTER-HOSPITAL CONFERENCE 21 DEC. 2007

INTER-HOSPITAL CONFERENCE 21 DEC. 2007

Physical examination • Thai male, not pale, no jaundice • v/s T 37˚C PR

Physical examination • Thai male, not pale, no jaundice • v/s T 37˚C PR 80/min BP 120/80 mm. Hg • Heart : normal • Lung : clear • Abdomen : soft, not tender, no hepatomegaly • Neuro sing : WNL

ENT Examination • AR : normal mucosa, no discharge • PR : no mass,

ENT Examination • AR : normal mucosa, no discharge • PR : no mass, no discharge • OC : ulcerative lesion at Lt. lateral tongue size 0. 5 x 0. 5 cm. • IDL : no mass, TVC move bilateral • Neck : no palpable lymph node

Management?

Management?

BIOPSY : Negative for malignancy

BIOPSY : Negative for malignancy

DIFFERENTIAL DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

ENT Examination • OC : ulcerative lesion at Lt. lateral tongue size 0. 5*0.

ENT Examination • OC : ulcerative lesion at Lt. lateral tongue size 0. 5*0. 5 cm. , submucosal lesion 2*3 cm. , no limited tongue movement

INVESTIGATION

INVESTIGATION

INVESTIGATION • A. • B. • C. • D. • E.

INVESTIGATION • A. • B. • C. • D. • E.

DIAGNOSIS AND MANAGEMENT

DIAGNOSIS AND MANAGEMENT

DIAGNOSIS

DIAGNOSIS

DIAGNOSIS • CA Tongue T 2 N 0 M 0

DIAGNOSIS • CA Tongue T 2 N 0 M 0

MANAGEMENT • Surgery? • RT?

MANAGEMENT • Surgery? • RT?

MANAGEMENT • Surgery? • RT? Wide excision?

MANAGEMENT • Surgery? • RT? Wide excision?

DIAGNOSIS AND MANAGEMENT • Dx. CA Tongue T 2 N 0 M 0 •

DIAGNOSIS AND MANAGEMENT • Dx. CA Tongue T 2 N 0 M 0 • Rx. Lt. Hemiglossectomy with primary closure with Lt. SND I-IV

Surgical Pathology Report • Tongue : consists of Lt. half portion of tongue, measuring

Surgical Pathology Report • Tongue : consists of Lt. half portion of tongue, measuring 5*3*2. 5 cm. The outer surface reveals an ulcerated light tan firm mass, measuring 2. 7*1. 8*0. 8 cm. , occupying the Lt. half of tongue, 0. 5 cm. from medial resected margin and 0. 5 cm. from deep resected margin • Lymph node group I-IV : No evidence of malignancy

Management • Combine Post-Op. RT? • Combine Chemotherapy?

Management • Combine Post-Op. RT? • Combine Chemotherapy?

Management of the N 0 Neck in CA Oral cavity

Management of the N 0 Neck in CA Oral cavity

Evaluation of the N 0 Neck • The reported false negative rate in assessing

Evaluation of the N 0 Neck • The reported false negative rate in assessing of cervical LN metastasis by palpation is 20%-50% • Factor affecting : • • • The experience of the examiner The patient’s body The previous treatment – Sx / RT

Evaluation of the N 0 Neck • Structure in neck mistake • Transverse process

Evaluation of the N 0 Neck • Structure in neck mistake • Transverse process of atlas • Carotid bifurcation • Submandibular gland

Evaluation of the N 0 Neck • Digital palpation • CT / MRI •

Evaluation of the N 0 Neck • Digital palpation • CT / MRI • Ultrasound guided FNAB

Evaluation of the N 0 Neck • Malignancy criteria for CT/MRI • LN >

Evaluation of the N 0 Neck • Malignancy criteria for CT/MRI • LN > 15 mm. in level II • LN > 10 mm. in other levels • Group of ≥ 3 nodes ( 1 -2 mm. ) • Central necrosis • Loss of tissue planes ( fat plane)

N 0 Neck affecting the recurrent/survival rate Oral cavity CA Type N 0 1

N 0 Neck affecting the recurrent/survival rate Oral cavity CA Type N 0 1 node 2 nodes ≥ 3 nodes 5 years survival 75% 49% 30% 15%

Therapeutic modalities for the N 0 neck • Prophylactic Neck dissection • Prophylactic Neck

Therapeutic modalities for the N 0 neck • Prophylactic Neck dissection • Prophylactic Neck irradiation • Observation with therapeutic ND once regional metastasis become appearance

The N 0 neck in oral cavity CA • Byers et al : the

The N 0 neck in oral cavity CA • Byers et al : the prediction of nodal metas. In primary oral tongue SCCA • • • The depth of muscle invasion N stage The degree of differentiation of the 1˚ tumor • T 1 N 0 with muscle invasion < 4 mm. , WD 14% chance of nodal involvement

The N 0 neck in oral cavity CA • SCCA of oral cavity the

The N 0 neck in oral cavity CA • SCCA of oral cavity the sites with < 20% occult metastasis : • • • T 1/T 2 lip T 1/T 2 oral tongue < 4 mm in thickness T 1/T 2 FOM < 1. 5 mm in thickness

Surgical therapy in the N 0 neck with oral cavity CA • SOHND •

Surgical therapy in the N 0 neck with oral cavity CA • SOHND • Minimal morbidity • Reduces the risk of occult disease • Avoid the undesirable side effect of RT ( RT is reserved for possible future tx. of second primary tumor(

RT in the N 0 neck with oral cavity CA • An alternative treatment

RT in the N 0 neck with oral cavity CA • An alternative treatment to SOHND • PORT of the surgically treated primary tumor site, the neck has not been dissected, and the risk of occult regional dz. is substantial • Primary tumor is treated with RT and the risk of occult node > 20%

Elective neck dissection VS Elective neck irradiation ENI reduced neck failure rate in pt

Elective neck dissection VS Elective neck irradiation ENI reduced neck failure rate in pt with control primary tumor and N 0 neck from 18% to 1. 9% • In T 1 N 0 SCCA oral tongue, ENI provided 95% control rate for neck recurrences compare with 38% without ENI • Modality is chosen to Tx primary cancer may also help in formulating a decision as to how to tx the neck •

Elective neck dissection VS Elective neck irradiation • Prophylactic neck RT provides equal control

Elective neck dissection VS Elective neck irradiation • Prophylactic neck RT provides equal control rate for neck metastasis to prophylactic ND

THANK YOU FOR YOUR ATTENTION

THANK YOU FOR YOUR ATTENTION

Combined modality of treatment • perineural spread • intravascular spread • intralymphatic spread +ve

Combined modality of treatment • perineural spread • intravascular spread • intralymphatic spread +ve margin • 2 histo. Positive LN • multiple +ve LN • extracapsular spread •

Management of contralateral N 0 • 14% incidence of involvement of contralateral neck node

Management of contralateral N 0 • 14% incidence of involvement of contralateral neck node regardless of tumor stage • If primary oral cavity cancer is midline location, bilaterally, along the tip of tongue or approaches or cross the midline

BASIC LAB. • • CBC : Hct. 36% WBC 11, 200 ( N 72.

BASIC LAB. • • CBC : Hct. 36% WBC 11, 200 ( N 72. 2% L 21% E 2. 1% M 3. 9%) BUN 5 Cr 0. 5 Na 137 K 4. 3 Cl 106 CO 2 25 FBS : 107 LFT : Alk. 59 SGPT 12 SGOT 17 TB 0. 63 TP 7. 8 Alb 4. 6 EKG : Normal CXR : No active pulmonaly lesion

BIOPSY. • Lt. Lateral tongue : Squamous cell carcinoma, moderate differentiated

BIOPSY. • Lt. Lateral tongue : Squamous cell carcinoma, moderate differentiated

N 0 in early SCCA oral cavity Most important prognostic factor in Mx of

N 0 in early SCCA oral cavity Most important prognostic factor in Mx of oral SCCA is status of cervical LN. • Present of metastasis to cervical LN can reduce curative rate by 50% • 3 Tx options are available. • • Observation with therapeutic ND once regional metastasis become appearance Elective neck RT Elective neck dissection

Morbidities of associated ENI • Xerostomia • Dsyphagia • Increased oral passage time •

Morbidities of associated ENI • Xerostomia • Dsyphagia • Increased oral passage time • Mucositis • Pain • Increased complication if salvage sx. • Long duration of tx.